Approval for a new single-operator exchange catheter with a self-contained contrast displacement system.  The device, as modified, will be marketed under the trade name scimed(r) rebel(tm) ptcqa cathether and is indicated for balloon dilatation of the stenotic protion of a coronary artyer or bypass grat stenosis for the purpose of improving myocardial perfusion.